^
Association details:
Biomarker:CSMD1 overexpression
Cancer:Breast Cancer
Drug:anastrozole (Aromatase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action

Published date:
07/23/2020
Excerpt:
Overexpression of CSMD1 sensitized AI-resistant cells to anastrozole but not to the other two AIs.
DOI:
10.1172/jci.insight.137571